Table 4.
Enriched GO BPs (FDR < 5%) that overlap between platforms®.
GOID | GO BP Term | Microarray | RNA-seq | TempO-seq | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Count | % | Pop Hits | FE | Count | % | Pop Hits | FE | Count | % | Pop Hits | FE | ||
GO:0001666 | Response to hypoxia | 119 | 2.11 | 270 | 1.55 | 99 | 2.18 | 270 | 1.59 | 39 | 3.32 | 270 | 2.28 |
GO:0001731 | Formation of translation preinitiation complex | 17 | 0.30 | 24 | 2.50 | 18 | 0.40 | 24 | 3.24 | 9 | 0.77 | 24 | 5.92 |
GO:0001889 | Liver development | 85 | 1.51 | 145 | 2.07 | 81 | 1.78 | 145 | 2.42 | 32 | 2.72 | 145 | 3.48 |
GO:0006413 | Translational initiation | 32 | 0.57 | 52 | 2.17 | 29 | 0.64 | 52 | 2.41 | 13 | 1.11 | 52 | 3.95 |
GO:0006446 | Regulation of translational initiation | 19 | 0.34 | 31 | 2.16 | 17 | 0.37 | 31 | 2.37 | 12 | 1.02 | 31 | 6.11 |
GO:0006457 | Protein folding | 57 | 1.01 | 112 | 1.79 | 49 | 1.08 | 112 | 1.89 | 17 | 1.45 | 112 | 2.40 |
GO:0006629 | Lipid metabolic process | 44 | 0.78 | 89 | 1.74 | 42 | 0.93 | 89 | 2.04 | 17 | 1.45 | 89 | 3.01 |
GO:0006631 | Fatty acid metabolic process | 33 | 0.58 | 60 | 1.94 | 32 | 0.71 | 60 | 2.31 | 12 | 1.02 | 60 | 3.16 |
GO:0006635 | Fatty acid beta-oxidation | 35 | 0.62 | 46 | 2.68 | 31 | 0.68 | 46 | 2.92 | 23 | 1.96 | 46 | 7.89 |
GO:0006637 | Acyl-coa metabolic process | 19 | 0.34 | 28 | 2.39 | 16 | 0.35 | 28 | 2.47 | 9 | 0.77 | 28 | 5.07 |
GO:0006695 | Cholesterol biosynthetic process | 17 | 0.30 | 26 | 2.30 | 17 | 0.37 | 26 | 2.83 | 8 | 0.68 | 26 | 4.86 |
GO:0006749 | Glutathione metabolic process | 31 | 0.55 | 52 | 2.10 | 28 | 0.62 | 52 | 2.33 | 11 | 0.94 | 52 | 3.34 |
GO:0006915 | Apoptotic process | 157 | 2.78 | 366 | 1.51 | 120 | 2.64 | 366 | 1.42 | 41 | 3.49 | 366 | 1.77 |
GO:0006953 | Acute-phase response | 25 | 0.44 | 38 | 2.32 | 19 | 0.42 | 38 | 2.16 | 9 | 0.77 | 38 | 3.74 |
GO:0006979 | Response to oxidative stress | 76 | 1.35 | 146 | 1.83 | 61 | 1.34 | 146 | 1.81 | 22 | 1.87 | 146 | 2.38 |
GO:0007568 | Aging | 150 | 2.66 | 315 | 1.68 | 125 | 2.75 | 315 | 1.72 | 51 | 4.34 | 315 | 2.56 |
GO:0007584 | Response to nutrient | 69 | 1.22 | 137 | 1.77 | 59 | 1.30 | 137 | 1.86 | 19 | 1.62 | 137 | 2.19 |
GO:0007623 | Circadian rhythm | 52 | 0.92 | 121 | 1.51 | 46 | 1.01 | 121 | 1.64 | 18 | 1.53 | 121 | 2.35 |
GO:0009636 | Response to toxic substance | 65 | 1.15 | 119 | 1.92 | 61 | 1.34 | 119 | 2.22 | 30 | 2.55 | 119 | 3.98 |
GO:0009749 | Response to glucose | 54 | 0.96 | 106 | 1.80 | 47 | 1.04 | 106 | 1.92 | 18 | 1.53 | 106 | 2.68 |
GO:0010033 | Response to organic substance | 72 | 1.28 | 152 | 1.67 | 69 | 1.52 | 152 | 1.96 | 32 | 2.72 | 152 | 3.32 |
GO:0010243 | Response to organonitrogen compound | 35 | 0.62 | 68 | 1.81 | 34 | 0.75 | 68 | 2.16 | 14 | 1.19 | 68 | 3.25 |
GO:0014070 | Response to organic cyclic compound | 138 | 2.45 | 272 | 1.79 | 128 | 2.82 | 272 | 2.04 | 50 | 4.26 | 272 | 2.90 |
GO:0031100 | Organ regeneration | 45 | 0.80 | 91 | 1.74 | 39 | 0.86 | 91 | 1.85 | 22 | 1.87 | 91 | 3.82 |
GO:0031667 | Response to nutrient levels | 49 | 0.87 | 112 | 1.54 | 42 | 0.93 | 112 | 1.62 | 22 | 1.87 | 112 | 3.10 |
GO:0032355 | Response to estradiol | 91 | 1.61 | 201 | 1.60 | 81 | 1.78 | 201 | 1.74 | 40 | 3.40 | 201 | 3.14 |
GO:0032496 | Response to lipopolysaccharide | 114 | 2.02 | 280 | 1.43 | 101 | 2.23 | 280 | 1.56 | 39 | 3.32 | 280 | 2.20 |
GO:0032869 | Cellular response to insulin stimulus | 66 | 1.17 | 123 | 1.89 | 56 | 1.23 | 123 | 1.97 | 26 | 2.21 | 123 | 3.34 |
GO:0033539 | Fatty acid beta-oxidation using acyl-coa dehydrogenase | 16 | 0.28 | 19 | 2.97 | 15 | 0.33 | 19 | 3.42 | 9 | 0.77 | 19 | 7.48 |
GO:0042493 | Response to drug | 246 | 4.36 | 528 | 1.64 | 211 | 4.65 | 528 | 1.73 | 82 | 6.98 | 528 | 2.45 |
GO:0042542 | Response to hydrogen peroxide | 40 | 0.71 | 78 | 1.81 | 31 | 0.68 | 78 | 1.72 | 14 | 1.19 | 78 | 2.83 |
GO:0043065 | Positive regulation of apoptotic process | 133 | 2.36 | 338 | 1.39 | 115 | 2.53 | 338 | 1.47 | 53 | 4.51 | 338 | 2.47 |
GO:0043066 | Negative regulation of apoptotic process | 203 | 3.60 | 517 | 1.38 | 177 | 3.90 | 517 | 1.48 | 60 | 5.11 | 517 | 1.83 |
GO:0043434 | Response to peptide hormone | 63 | 1.12 | 129 | 1.72 | 51 | 1.12 | 129 | 1.71 | 19 | 1.62 | 129 | 2.32 |
GO:0045471 | Response to ethanol | 82 | 1.45 | 193 | 1.50 | 74 | 1.63 | 193 | 1.66 | 34 | 2.89 | 193 | 2.78 |
GO:0046686 | Response to cadmium ion | 27 | 0.48 | 45 | 2.11 | 22 | 0.48 | 45 | 2.12 | 12 | 1.02 | 45 | 4.21 |
GO:0051289 | Protein homotetramerization | 37 | 0.66 | 76 | 1.72 | 34 | 0.75 | 76 | 1.94 | 20 | 1.70 | 76 | 4.15 |
GO:0051301 | Cell division | 83 | 1.47 | 179 | 1.63 | 63 | 1.39 | 179 | 1.52 | 27 | 2.30 | 179 | 2.38 |
GO:0051384 | Response to glucocorticoid | 69 | 1.22 | 133 | 1.83 | 56 | 1.23 | 133 | 1.82 | 23 | 1.96 | 133 | 2.73 |
GO:0051603 | Proteolysis involved in cellular protein catabolic process | 28 | 0.50 | 51 | 1.93 | 24 | 0.53 | 51 | 2.04 | 11 | 0.94 | 51 | 3.40 |
GO:0055088 | Lipid homeostasis | 27 | 0.48 | 42 | 2.27 | 24 | 0.53 | 42 | 2.47 | 11 | 0.94 | 42 | 4.13 |
GO:0055114 | Oxidation-reduction process | 314 | 5.56 | 651 | 1.70 | 262 | 5.77 | 651 | 1.74 | 88 | 7.49 | 651 | 2.13 |
GO:0070542 | Response to fatty acid | 26 | 0.46 | 39 | 2.35 | 25 | 0.55 | 39 | 2.77 | 11 | 0.94 | 39 | 4.45 |
GO:0071407 | Cellular response to organic cyclic compound | 53 | 0.94 | 122 | 1.53 | 48 | 1.06 | 122 | 1.70 | 22 | 1.87 | 122 | 2.85 |
GO:0071456 | Cellular response to hypoxia | 57 | 1.01 | 137 | 1.47 | 49 | 1.08 | 137 | 1.55 | 22 | 1.87 | 137 | 2.53 |
GO:0097421 | Liver regeneration | 41 | 0.73 | 55 | 2.63 | 30 | 0.66 | 55 | 2.36 | 14 | 1.19 | 55 | 4.02 |
GO:0098609 | Cell-cell adhesion | 102 | 1.81 | 211 | 1.70 | 82 | 1.81 | 211 | 1.68 | 27 | 2.30 | 211 | 2.02 |
GO:1904871 | Positive regulation of protein localization to Cajal body | 8 | 0.14 | 8 | 3.52 | 8 | 0.18 | 8 | 4.33 | 6 | 0.51 | 8 | 11.84 |
GO:1904874 | Positive regulation of telomerase RNA localization to Cajal body | 13 | 0.23 | 15 | 3.05 | 12 | 0.26 | 15 | 3.46 | 8 | 0.68 | 15 | 8.42 |
Universe is 17,535. List totals: Microarray: 4,976; RNA-Seq: 4,053; TempO-Seq: 1,111. Enrichment performed using UniGene cluster IDs and the Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.8.